Toggle navigation
HOME
THE COMPANY
OVERVIEW
OUR BUSINESS
BOARD OF DIRECTORS
MANAGEMENT TEAM
INFRASTRUCTURE
PRODUCTS
INVESTOR
MEDIA
CAPLIN CARES
CONTACT US
Caplin Point
Providing remedies
BRINGING SMILES
to people
We Choose To Be
DIFFERENT
We always took
the road less travelled and
that has made
ALL THE DIFFERENCE
INVESTOR
Postal Ballot Notice
Postal Ballot Notice - 2019
Postal Ballot Notice - 2018
Annual Reports
2020-21
Disclosure on ESOP
Annual Report
Newspaper Advertisement–Dispatch of Annual Report
Newspaper Advertisement – AGM Intimation
Annual Return 2020-21
2019-2020
Annual Report
2018 -2019
Annual Report
Attendence Slip
E - Voting Instruction
Notice
2017 -18
Annual Report
Attendence Slip
E- voting instruction
Notice
2016-17
Annual Report
Notice
Addendum to Annual Report 2016-17
2015-16
Annual Report
Attendance Slip
2013-14
Annual Report
Attendance Slip
2012-13
2014-15
2014-15
2011-12
2010-11
2009-10
2008-09
Terms and Conditions for Appointment of Independent Director
Terms and Conditions for Appointment of Independent Director.
Financial Results
2021-22
June 2021
June 2021
2020-21
March 2021
June 2020
December 2020
September,2020
2019 - 20
Mar 2020
December 2019
September 2019
June 2019
2018-19
December 2018
March 2019
September 2018
June 2018
2017-18
March -2018
September 2017
June 2017
December 2017
2016-17
March 2017
December 2016
September 2016
June 2016
2015-16
Mar 2016
Dec 2015
Sep 2015
2014-15
June 2015
Mar 2015
Dec 2014
Sep 2014
2013-14
June 2014
Mar 2014
Dec 2013
Sep 2013
2012-13
2011-12
2010-11
2009-10
2008-09
Company Polices & Code of Conduct
FAMILIARIZATION PROGRAMME FOR INDEPENDENT DIRECTORS.
FAIR DISCLOSURE OF UNPUBLISHED PRICE SENSITIVE INFORMATION
RELATED PARTY TRANSACTION POLICY.
Dividend Distribution Policy
CRITERIA FOR MAKING PAYMENT TO NON-EXECUTIVE DIRECTOR
POLICY ON MATERIAL SUBSIDIARY.
POLICY ON PRESERVATION OF RECORDS/ ARCHIVAL POLICY.
POLICY FOR DETERMINATION OF MATERIALITY OF EVENTS.
FAMILIARIZATION PROGRAMME FOR INDEPENDENT DIRECTORS.
NOMINATION AND REMUNERATION POLICY.
CODE OF CONDUCT.
WHISTLE BLOWER POLICY(VIGIL MECHANISM).
CORPORATE SOCIAL RESPONSIBILITY(CSR)POLICY.
RELATED PARTY TRANSACTION POLICY. 2016
Stock Exchange Intimation
05.08.2021 - Board Meeting Intimation
06.05.2021 - Board Meeting Intimation
29.01.2021 - Board Meeting Intimation
29.10.2020 - Board Meeting Intimation
30.10.2020 - Conference Call
30.09.2020 - Trading Window Closure
29.09.2020 - Outcome of the AGM
14.09.2020- Revised Book Closure Dates
12.09.2020- Notice of Book Closure
10.08.2020-Outcome of the Board Meeting
03.08.2020- Conference Call
03.08.2020- Board Meeting Intimation
07.07.2020 - Press Release
18.06.2020-Outcome of Board Meeting
10.06.2020 - Board Meeting Intimation
10.06.2020 -Conference Call
12.06.2020- Press Release
13.04.2020- Press Release
31.03.2020- Trading Window Closure
26.03.2020- Press Release
04.03.2020-Outcome of the Board Meeting
28.02.2020-Board Meeting Intimation
05.02.2020- Outcome of the Board Meeting
27.01.2020 - Board Meeting Intimation
05.12.2019 - Demise of a Director
03.12.2019- Press Release
30.10.2019 - Re-appointment of Independent Director
30.10.2019 - Un-audited financial results and Press release
21.10.2019 - Board Meeting Intimation
30.09.2019 - Intimation of Trading window closure
13.09.2019 - Summary of proceedings of the 28th Annual General Meeting
12.08.2019 - Un-audited financial results and Press release
02.08.2019 - Board Meeting Intimation
25.07.2019 - Press Release
18.07.2019 - Press Release
29.06.2019 - Closure of Trading Window
20.06.2019 - Disclosure of Related Party Transactions pursuant to Reg 23(9) of SEBI (LODR) Regulations, 2015
17.06.2019 - Press Release
31.05.2019 - Allotment of Shares under ESOP
22.05.2019 - Audited Financial Results and Press Release
13.05.2019 - Press Release
11.04.2019 Resignation of Dr Philip Ashok Karunakaran,Whole-time Director
08.04.2019 - Press Release
05.04.2019-Closure of Trading Window
22.03.2019 - Press Release
10.02.2019 - Allotment of Shares under ESOP
11.02.2019 Unaudited financial results
31.01.2019 - Earnings Conference Call
24.01.2019 - Board Meeting Intimation
18.01.2019 - Outcome of the Board Meeting
18.01.2019 - Execution of Business Transfer Agreement
11.01.2019 -Intimation for Board Meeting
11.01.2019- Outcome of the Board Meeting
02.01.2019-Board Meeting Intimation
17.12.2018 - Incorporation of Wholly Owned Subsidiary Company
30.11.2018 - Notice of Postal Ballot
19.11.2018 - Outcome of the Board Meeting
02.11.2018 - Outcome of the Board Meeting
09.10.2018 - Board Meeting intimation
29.09.2018 - Summary of Proceedings of the 27th Annual General Meeting
14.09.2018 - Joint Venture Agreement
07.08.2018 - SUCCESSFUL US FDA INSPECTION AT STERILE INJECTABLE SITE (CP IV)
04.08.2018 - Intimation of book closure date
04.08.2018 - Notice of the AGM
12.07.2018 - Board Meeting Intimation
06.06.2018 - Press Release
01.06.2018- Investor Information
28.05.2018- Audited Financial Results & Dividend and press release for 31.03.2018
08.05.2018 - Re-appointment of Mr R Viswanathan as an Independent Director.
02.05.2018- Board meeting intimation
29.03.2018 - Cessation of Director
12.03.2018 - Outcome of the Board Meeting
01.03.2018- Board Meeting Intimation
15.02.2018 - Allotment of shares under ESOP
07.02.2018 - Re-appointment of director
07.02.2018 - Grant of options
10.01.2018- Board Meeting Intimation
09.11.2017- Un-audited financial results and press release
09.11.2017- outcome of the Board Meeting
16.10.2017- Board Meeting Intimation
22.09.2017 -Proceedings of AGM
21.09.2017 -Outcome of the AGM
20.09.2017- Press Release.
28.08.2017 - 26th Annual General Meeting Notice
28.08.2017 - Intimation of Book closure Date
07.08.2017 - Out come of the Board Meeting
20.07.2017-Change in RTA
10.05.2017 - Press Release
10.05.2017- Dividend Recommendation
08.05.2017 - Press Release
17.04.2017 - Board Meeting Intimation
05.04.2017 - Grant of Stock Options
10.02.2017 - Allotment of Equity shares
12.01.2017 - Board Meeting Intimation
11.11.2016 - Out Come of Conference Call
09.11.2016 - Appointment of Mr D Sathyanarayanan as an Additional Director
29.10.2016 - US FDA
18.10.2016 - Board Meeting Intimation
17.10.2016 - New ISIN
05.10.2016 -Record date
14.09.2016 - Voting Results - AGM, September 2016
14.09.2016 - Proceedings of 25th Annual General Meeting - September 2016
12.09.2016 - Outcome of AGM - September 2016
25.08.2016 - Compliance under Regulation 30 of SEBI (LODR), 2015.
22.08.2016 - Book Closure
05.08.2016 - sub division of shares.
05.08.2016 – Press Release.
28.07.2016 - Updates for the ensuing Board Meeting.
21.07.2016 - Sub Division of Equity Shares.
27.05.2016 – Press Release.
27.05.2016 – Board Recommends Final Dividend.
17.05.2016 - Board Meeting Intimation.
02.05.2016 - Change in Designation of Mr D P Mishra
18.03.2016 - AUTHORISATION TO KMP'S FOR DETERMINING MATERIALITY OF EVENTS.
Shareholding Pattern
June 30, 2021
March 31, 2021
December 31,2020
December 31,2020
September 30,2020
June 30 2020
March 31, 2020
December 31,2019
September 30, 2019
June 30, 2019
March 31,2019
December 31,2018
June 30,2018
March 31,2018
December 31, 2017
September 30,2017
March 31,2017
December 31, 2016
September 30,2016
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015
June 30, 2015
Mar 31, 2015
Dec 31, 2014
Sep 30, 2014
June 30, 2014
March 31, 2014
December 31, 2013
September 30, 2013
June 30, 2013
March 31, 2013
December 31, 2012
September 30, 2012
June 30,2012
March 31, 2012
December 31, 2011
September 30, 2011
June 30, 2011
Unpaid Dividend Account
2018 - 19
2017 -18
2016-17
2015-16 Final Dividend
2015-16 Interim Dividend
2014-15
2013-14
2012-13
2011-12
Forms
E-Mail Registration Form
Securities Transfer Form SH 4
Form SH 13-Nomination Form
Voting Results
Annual General Meeting-2020
Annual General Meeting 2019
Postal Ballot Result
Annual General Meeting 2018
Annual General Meeting - 2017
Annual General Meeting - 2016
Annual General Meeting-2015
Annual General Meeting-2014
Composition of Committees
Composition of Committees
Composition of Committees
Composition of Committees
Composition of Committees
Composition of Committees
Composition of Committees
Composition of Committees
Transcript of Investors Call
06.05.2021-Q4FY21 Earnings Conference Call Transcript
04.02.2021-Q3FY21 Earnings Conference Call Transcript
06.11.2020-Q2FY21 Earnings Conference Call Transcript
11.08.2020 -Q1FY21 Earning Conference Call Transcript
18.06.2020 -Q4 FY Earnings Conference Call Transcript
30.10.2019 - Q2 FY 20 Earnings Conference Call Transcript
Investor Presentation
June 2021
March 2021
December 2020
September,2020
June, 2020
March,2020
December,2019
February, 2019
Shares Transferred to Investor Education and Protection Fund
2019
2018
Disclosure of Related Party Transactions pursuant to Reg 23(9) of SEBI (LODR) Regulations, 2015
September 30,2020
March 31,2020
September 30,2019
March 31, 2019
Shares which are liable to be transferred to IEPF -2019
2019
Shares which are liable to be transferred to IEPF -2020
2020
Press Release
08.09.2021 Caplin Steriles gets USFDA approval for Labetalol Hydrochloride Injection USP
Press Release for Un-Audited Financial Results for Quarter ended June 30, 2021
Press Release: Financial Results for the Quarter and Year Ended 31st March 2021
Press Release for Un-Audited Financial Results for Quarter and Nine months ended December 31, 2020
22.01.2021-CAPLIN STERILES GETS USFDA APPROVAL FOR ARGATROBAN INJECTION
18.01.2020-CAPLIN STERILES ENTERS INTO A STRATEGIC PARTNERSHIP WITH JAMP PHARMA GROUP FOR CANADA
24.12.2020-CAPLIN STERILES GETS USFDA APPROVAL FOR ETOMIDATE INJECTION USP
05.10.2020- Press Release for Un-audited Financial Results for the quarter/half year ended September 30,2020
10.08.2020- Press Release for Un-audited Financial Results for the quarter ended June 30,2020
Subsidiary Accounts
Subsidiary Accounts 2020 – 2021
Caplin Steriles Limited
Caplin Steriles Limited
Caplin Point Far East Limited, Hong Kong
Caplin Point (S) Pte. Ltd
Argus Salud Pharma LLP
Caplin Point Colombia SAS, Colombia
Subsidiary Accounts 2019 – 2020
Caplin Steriles Limited
Caplin Point (S) Pte. Ltd.
Argus Salud Pharma
Caplin Point Far East Limited, Hong Kong
Caplin Point Colombia SAS, Colombia
Subsidiary Accounts 2018 - 2019
Caplin Steriles Limited
Argus Salud Pharma
Caplin Point Far East Limited, Hong Kong
Caplin Point Colombia SAS, Colombia
Subsidiary Accounts 2017 – 2018
Caplin Point Colombia SAS
Argus Salud Pharma
Caplin Point Far East Limited, Hong Kong
Corporate Governance
June 2021
March 2021
Contact Details of Key Managerial Personnel's
Investor Grievance Redressal
For Any Queries And Complaint Please
Email to:
investor@caplinpoint.net